Joint revision procedures place a tremendous economic burden on the healthcare system. Current figures from the Norway show that the cost of revision surgeries exceeded NOK 2.5 Billion in 2012 . Data from The Norwegian Arthroplasty Register (NAR) demonstrate that 14.3% of all hip and 8.5% of all knee joint replacement surgeries are revision surgeries . In UK 2012 12% of all hip joint and 6.5% of all knee joint replacement surgeries are revisions .
Current figures from the US show that revision procedures account for approximately 19% and 8% of all total hip and knee replacements, respectively that is reimbursed by Medicare . Medicare reimbursements for revision of total joint replacements have been projected to exceed $8.5 billion by 2015.
As a result of improved surgical techniques and total joint artroplasty (TJA) becoming a routine surgery, the age of the patients receiving TJA is steadily decreasing and so is the threshold level of arthritis necessitating the procedure.